← All thirteen providers

Eden

Video visits · Pharmacy: 503A

Budding4 / 14 $129month-to-month 503A Visit Eden →

Eden puts an actual clinician on video, which is rarer here than it should be, and pairs that with 503A compounding so doses can be prepared in custom increments. Both are real advantages, and if what you have missed most is talking to a person, Eden offers it.

The conversation, though, is about weight. There is no gynecologic or whole-person framing in the published model, so the live access — the thing you are paying extra for — is spent on a consultation that does not have room for the rest of your history.

Here is how Eden reads against each promise of the Whole-Woman Charter. Each promise is marked none, partial or strong; price is shown but is never part of the rating. GLP-1 medications are not a treatment for endometriosis.

strong partial none
Sees the whole you None
Believed, not dismissed None
Metabolic support, honestly framed None
A dose made for your body Partial
A human who answers Partial
Care that lasts None
Honest, upfront cost Strong

What the price includes

What Eden’s published price covers, taken from its own pages and checked October 2026. “Not listed on their site” means we could not find it published.

Billing & commitment
Monthly; no annual or long-term plan required. The same price at every dose.
Clinician visits
A clinician reviews your intake within 24 hours, then ongoing check-ins. No visit schedule stated.
Dose adjustments
Your provider can adjust the plan as you respond; the price stays flat.
Human support
24/7 human support and 24/7 provider messaging.
Coaching / community
Daily virtual workouts with Eden coaches and a member community.
Cancellation
Pause or cancel from the patient portal. Orders already at the pharmacy may not be cancellable.
Extra fees
No separate membership fee. Expedited shipping is free.

What $129 covers

The plan includes video consultation and 503A titration at one published price across every dose, with no separate membership fee. On delivery quality this is a better model than most asynchronous services at similar money. The Charter still scores the first three rows at zero because it measures whether care is built to see the whole person, and Eden publishes nothing in that direction. Dose fit and human help sit at partial; cost scores strong because the number is readable before you commit.

An honest price, on a narrow frame

Eden's pricing is now among the simplest on this page: the same monthly figure whether you are on a starting dose or a higher one. That clarity is worth crediting. What it buys, though, is a weight consultation. The low price does not change the fact that your endometriosis history has no obvious place in the visit, so the value depends on whether that context is already held somewhere else.

Where Eden fits

  • Video contact with a clinician is something you want and will actually use.
  • You want 503A dose flexibility and have gynecologic care handled elsewhere.
  • You want one predictable price that does not climb with your dose.

Where it does not

  • You want your endometriosis history to be part of the consultation.
  • You want a provider who asks about pain, cycles and hormonal medication by default.
  • You want a maintenance plan published before committing.

Before you hand over a card

Put these to Eden in writing, and keep the reply.

  1. Does the monthly price stay the same if I move to a higher dose?
  2. Is it the same clinician at each video visit?
  3. Can I raise non-weight symptoms in the consult, and will they be recorded?
  4. How are dose increments decided?

Where this leaves you

Eden delivers a competent conventional weight service with genuine live contact and one of the clearest prices here, and it rates low only because this Charter measures something Eden does not attempt. If your endometriosis care is solid elsewhere and you want video access at a predictable cost, it is a reasonable choice.

What is above comes from what this provider chooses to publish, and providers revise their terms without saying so — treat it as a starting point and check it yourself. Havelle is editorial, not clinical: none of this is medical advice, and GLP-1 medications are not a treatment for endometriosis.


Weigh the Charter by what matters to you →